Jane Street’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-1,408
Closed -$243K 4388
2015
Q1
$243K Sell
1,408
-10,527
-88% -$1.55M ﹤0.01% 2710
2014
Q4
$1.37M Buy
11,935
+7,991
+203% +$968K 0.01% 851
2014
Q3
$616K Buy
3,944
+2,320
+143% +$336K 0.01% 1261
2014
Q2
$200K Sell
1,624
-9,086
-85% -$1M ﹤0.01% 2214
2014
Q1
$1.11M Buy
+10,710
New +$1.1M 0.01% 887
2013
Q4
Sell
-16,713
Closed -$1.12M 3282
2013
Q3
$1.12M Buy
+16,713
New +$1.15M 0.01% 1028

Other funds holding SLXP

Jane Street's SLXP Position: Q2 2015 in Review

Jane Street sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,408 shares — an estimated $243K sold.

Jane Street first reported a position in SLXP in Q3 2013 and held it in 6 quarters. The position peaked at $1.37M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Jane Street reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Jane Street sold 1,408 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $243K.
  • Jane Street first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 6 quarters.
  • Jane Street's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.37M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Jane Street's 13F filing for Q2 2015, filed 14 Aug 2015.